tirzepatide discontinued Call to action for drug interactions between and heart failure guideline-directed medical therapy sustainable wellness goals. A Major GLP-1 Drug Shortage

Description

Health Canadas target review time for generics is 180 days

501 Hardikar, H

Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro ) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements